Literature DB >> 8381283

Studies on the regulatory mechanisms of interleukin-8 gene expression in resting and IFN-gamma-treated neutrophils: evidence on the capability of staurosporine of inducing the production of interleukin-8 by human neutrophils.

M A Cassatella1, M Aste, F Calzetti, G Constantin, I Guasparri, M Ceska, F Rossi.   

Abstract

To understand how expression of IL-8 mRNA is regulated, we studied the effects of Staurosporine, H7, phorbol-myristate-acetate and Dexamethasone in human neutrophils subsequently treated with IFN-gamma. Our results can be summarized as follows: a) IL-8 mRNA steady state levels were enhanced in a dose dependent fashion by both Staurosporine and phorbol-myristate-acetate, were not influenced by H7, but were decreased by Dexamethasone; b) the negative effect of IFN-gamma on IL-8 mRNA accumulation was prevented by Staurosporine and phorbol-myristate-acetate, was not influenced by H7, and was potentiated by Dexamethasone; c) IL-8 mRNA induction caused by Staurosporine was accompanied by a time and dose dependent release of IL-8 into the PMN supernatants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381283     DOI: 10.1006/bbrc.1993.1099

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Possible roles of protein kinases in neutrophil chemotactic factor production by leucocytes in allergic inflammation in rats.

Authors:  J Tanabe; M Watanabe; S Kondoh; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

2.  Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells.

Authors:  O J Kwon; B T Au; P D Collins; J N Baraniuk; I M Adcock; K F Chung; P J Barnes
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

Review 3.  Interferon-gamma activation of polymorphonuclear neutrophil function.

Authors:  Terri N Ellis; Blaine L Beaman
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.